SEC Filings
| Filing date | Description | Form | Filing Group | Issuer | View |
|---|---|---|---|---|---|
| View HTML | An amendment to the SC 13G filing |
SC 13G/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Amendment to a previously filed 4 |
4/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Amendment to a previously filed 4 |
4/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | An amendment to a SC 13D filing |
SC 13D/A |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Initial filing by director officer or owner of more than ten percent. |
3 |
3,4,5
|
Eidos Therapeutics, Inc. | |
| View HTML | Statement of changes in beneficial ownership of securities |
4 |
3,4,5
|
Eidos Therapeutics, Inc. |
Displaying 11 - 20 of 62 results
Copyright Morningstar